Â
Market Overview and Growth Outlook
The global bioresorbable polymers market is expected to increase from US$560 million in 2025 to US$1.1 billion by 2031. The market outlook reflects the growing use of bioresorbable materials across orthopedic devices, therapeutic delivery systems, and regenerative medicine.
The bioresorbable polymers market is expected to grow at a CAGR of 12% during 2025–2031.
Medical device applications require materials capable of providing mechanical support while maintaining biocompatibility and controlled degradation. Bioresorbable polymers address these requirements through their ability to break down and become absorbed within the body.
Demand is also supported by increasing adoption of minimally invasive procedures and the development of advanced medical technologies.
The market’s long-term growth trends are closely linked to improvements in polymer science and the expanding medical applications of biodegradable materials.
The bioresorbable polymers market outlook highlights the importance of medical application diversity in supporting industry expansion. Orthopedic fixation remains the dominant application, while drug delivery represents the fastest-growing category. Regenerative medicine adds another area of material development. This combination of established and expanding uses creates demand for polymers with different mechanical characteristics and degradation profiles across medical technologies.
Request a free sample report: https://www.stratviewresearch.com/Request-Sample/bioresorbable-polymers-market#form
Market Segmentation Analysis
The bioresorbable polymers market is categorized by Type into Polylactic acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), and Polycaprolactone (PCL).
Polylactic acid (PLA) represents the largest type segment. Its established performance, availability, and cost-effectiveness support applications in orthopedic implants and sutures.
Polycaprolactone (PCL) is the fastest-growing type segment. The material’s slow degradation, biocompatibility, and mechanical strength support its adoption in tissue engineering, regenerative medicine, and long-term implants.
By Application, the market comprises Orthopedic Devices and Drug Delivery.
Orthopedic Devices hold the dominant application position. Temporary fixation requirements, including screws, plates, and pins, support their established market role.
Drug Delivery represents the fastest-growing application segment. Increasing use of controlled-release systems and the ability to improve bioavailability support demand for bioresorbable materials in advanced therapeutics.
Regional Market Insights
Asia-Pacific
Asia-Pacific is the fastest-growing regional market for bioresorbable polymers. Rising healthcare expenditure and increasing adoption of advanced medical technologies are the principal growth factors.
Investment in modern hospitals and regulatory support for innovative medical treatments is contributing to the regional industry outlook. China, India, and Southeast Asian countries are participating in this expansion, supported by medical tourism and broader access to advanced medical devices.
Emerging Trends Shaping the Bioresorbable Polymers Market
An important industry trend is the continued development of specialized medical-grade polymers. Advances in material properties are improving their suitability for medical applications requiring controlled degradation and mechanical strength.
Medical device manufacturers are also incorporating bioresorbable materials into orthopedic fixation technologies and advanced therapeutic systems.
Industry investment is supporting this development. In 2024, Evonik Industries AG expanded its RESOMER manufacturing capacity in Germany to respond to increasing demand for medical-grade bioresorbable polymers.
Corporate activity also reflects the strategic importance of these materials. In 2024, Ashland Global Holdings Inc. acquired the bioresorbable polymer division of Seqens SAS, strengthening its position in advanced drug delivery and surgical systems.
These developments illustrate the relationship between medical material innovation, manufacturing capacity, and competitive positioning.
Key Growth Drivers of the Market
- Diversification of medical applications: Increasing use across orthopedic devices, drug delivery, and regenerative medicine supports broader demand for bioresorbable materials.
- Demand for biocompatible materials: Medical applications require materials compatible with the body, supporting adoption of engineered polymers with controlled degradation.
- Expansion of minimally invasive procedures: Bioresorbable technologies can reduce certain follow-up procedures, supporting their use in advanced medical devices.
- Investment in medical polymer production: Manufacturing capacity expansion responds to growing requirements for medical-grade fixation and drug delivery materials.
- Advancement in therapeutic technologies: Controlled drug release and regenerative medicine applications increase the relevance of polymers with specialized performance characteristics.
Competitive Landscape
The global bioresorbable polymers market is moderately fragmented, comprising more than 80 participants. Competitive dynamics include pricing, service offerings, and regional market presence.
Top Companies in the Market
- Corbion N.V.
- Evonik Industries AG
- DSM Biomedical
- Poly-Med Inc
- Ashland Global Holdings Inc.
- KLS Martin Grou
- Foster Corporation
- Zeus Industrial Products Inc.
- SEQENS SAS
- Reva Medical LLC
Conclusion and Strategic Outlook
The bioresorbable polymers market is projected to reach US$1.1 billion by 2031, advancing from US$560 million in 2025 at a CAGR of 12%.
Orthopedic devices provide an established demand foundation, while drug delivery and regenerative medicine support additional market development.
The long-term industry outlook remains connected to material innovation, manufacturing investment, and the increasing integration of bioresorbable polymers into advanced medical technologies.
FAQs – Bioresorbable Polymers Market
- What is the expected market valuation by 2031?
The bioresorbable polymers market is forecast to reach US$1.1 billion by 2031. The market was valued at US$560 million in 2025.
- What is the anticipated CAGR of the industry?
The industry is expected to grow at a CAGR of 12% during 2025–2031. Expanding medical applications and advancements in polymer technology support this trajectory.
- Which factors are contributing to industry expansion?
Growth is supported by orthopedic fixation, controlled drug delivery, tissue engineering, and minimally invasive procedures. These applications require materials offering biocompatibility, controlled degradation, and suitable mechanical performance.
- Which geographic region has the fastest market growth?
Asia-Pacific is the fastest-growing region in the bioresorbable polymers market. Healthcare investment, expanding medical tourism, and adoption of advanced medical devices support regional development.
- What does the competitive landscape indicate about future opportunities?
The market is moderately fragmented, with more than 80 participants competing across pricing, service offerings, and regional presence. Medical-grade material innovation, therapeutic development, and manufacturing investment are important considerations for long-term opportunities.
